FDA Increasing Use Of Data Mining To Detect Early Safety Signals
Executive Summary
FDA is making increased use of data mining software to identify early drug safety signals in its adverse event database, Office of Pharmacoepidemiology & Statistical Science Director Paul Seligman said
You may also be interested in...
PhRMA Aims To Clarify Use Of AERS Signals Through Data Mining Studies
While all sources of reports to FDA's Adverse Event Reporting System make significant contributions to signal detection, foreign sources appear to be one of the strongest contributors, preliminary results from a PhRMA-sponsored study of the database suggest
PhRMA Aims To Clarify Use Of AERS Signals Through Data Mining Studies
While all sources of reports to FDA's Adverse Event Reporting System make significant contributions to signal detection, foreign sources appear to be one of the strongest contributors, preliminary results from a PhRMA-sponsored study of the database suggest
Adverse Event Analysis Could Leap Forward With New Statistical Techniques
Data mining the FDA Adverse Event Reporting System could take a leap forward as researchers validate a new statistical algorithm and publish results later this year